A new CEO is sparking optimism that this company can turn a corner to better days.
Which is the better buy between these two stocks in struggling industries?
It doesn't get any better than this.
Talks of Chapter 11 in an earnings filing should never be taken lightly.
If you've got a well-funded IRA, converting it to a Roth account may save you money in the long run.
These stocks started the week on a low note. Here's what investors need to know.
These winners delivered outsized gains today. Here's what investors need to know.
The company and the FDA concluded a successful end-of-phase 2 meeting for its lead drug candidate.